Lemtrada Patients Report Promising Results

Lemtrada Stroke Lawsuit News

Lemtrada is helping MS patients live a more normal life but the drug also carries serious, life-threatening side effects

Thursday, August 1, 2019 - Anti-multiple sclerosis medication Lemtrada can cause catastrophic and permanent damage to the blood vessels leading to the heart and brain. The result can be an immediate stroke or sudden death. Lemtrada use is restricted around the world to being a drug of last resort to be started in adults only when all others fail. Lemtrada's side effects have prompted patients to contact a Lemtrada stroke lawsuits attorney to seek monetary reimbursement for their medical expenses, lost wages and other related monetary damages. The news surrounding Lemtrada is not all bad, however, as patients are reporting "Greater Satisfaction with Treatment and Improvements in Quality of Life" according to Multiple Sclerosis News Today.

Sanofi Genzyme's Lemtrada (alemtuzumab) patients are reporting satisfactory results after switching to the anti-RRMS drug. Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) report significant and meaning full improvements in the quality of their life after receiving the twice per year infusion drip therapy. Lemtrada patients have completed the Treatment Satisfaction Questionnaire which querries a patient's overall satisfaction, the drug's effectiveness at reducing MS symptoms, the convenience of taking the medication, and also an evaluation of the drug's side effects. The company describes the drug's common side effects as "rash, headache, pyrexia, nasopharyngitis, nausea, urinary tract infection, fatigue, insomnia, upper respiratory tract infection, herpes viral infection, urticaria, pruritus, thyroid gland disorders, fungal infection, arthralgia, pain in extremity, back pain, and diarrhea."

Relapsing-remitting multiple sclerosis (RRMS), occurs mostly in young female patients and is characterized by being unable to control the movement of their torso, head, arms and legs, and also a lack of control of bowel movement and brain functions such as memory, speech, and eyesight. RRMS Attacks occur periodically and last for longer and longer periods of time until eventually, the attack is continuous. Lemtrada patients report that in best-case scenarios they have been able to return to a normal quality of life.

In November of 2018, The US Food and Drug Administration warned about Lemtrada (alemtuzumab) risks of stroke and blood vessel wall tears. "tears in the lining of arteries in the head and neck have occurred in patients with multiple sclerosis (MS) shortly after they received Lemtrada (alemtuzumab)." the agency reported. The agency also updated the boxed warning, the FDA's most serious warning reserved for drugs that can cause death in and of themselves, to reflect the drug's serious side effects. The FDA warns patients to seek immediate emergency room treatment if one experiences the following symptoms of a stroke or arterial dissection: "Sudden numbness or weakness in the face, arms, or legs, especially if it occurs on only one side of the body, sudden confusion, trouble speaking, or difficulty understanding speech, sudden trouble seeing in one or both eyes, sudden trouble with walking, dizziness, or loss of balance or coordination, or sudden severe headache or neck pain. " These symptoms usually occur within 3 days of a Lemtrada infusion.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.